pubmed-article:15385124 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15385124 | lifeskim:mentions | umls-concept:C0302592 | lld:lifeskim |
pubmed-article:15385124 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:15385124 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:15385124 | lifeskim:mentions | umls-concept:C1519429 | lld:lifeskim |
pubmed-article:15385124 | lifeskim:mentions | umls-concept:C0014822 | lld:lifeskim |
pubmed-article:15385124 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
pubmed-article:15385124 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
pubmed-article:15385124 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:15385124 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:15385124 | pubmed:dateCreated | 2004-9-23 | lld:pubmed |
pubmed-article:15385124 | pubmed:abstractText | The survival of cervix cancer patients is associated with their hemoglobin (Hgb) level during radiotherapy. The Southwest Oncology Group (SWOG) conducted a phase II trial to determine whether recombinant human erythropoietin (rHuEPO) safely corrects anemia during chemoradiotherapy for cervix cancer. | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:language | eng | lld:pubmed |
pubmed-article:15385124 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15385124 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15385124 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15385124 | pubmed:month | Oct | lld:pubmed |
pubmed-article:15385124 | pubmed:issn | 0090-8258 | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:LiuP YPY | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:AlbertsDavid... | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:MarkmanMaurie... | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:ConradMarcel... | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:GreerBenjamin... | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:LaveyRobert... | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:JiangCaroline... | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:WynnRaymond... | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:RobinsonWilli... | lld:pubmed |
pubmed-article:15385124 | pubmed:author | pubmed-author:ChangPui CPC | lld:pubmed |
pubmed-article:15385124 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15385124 | pubmed:volume | 95 | lld:pubmed |
pubmed-article:15385124 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15385124 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15385124 | pubmed:pagination | 145-51 | lld:pubmed |
pubmed-article:15385124 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:meshHeading | pubmed-meshheading:15385124... | lld:pubmed |
pubmed-article:15385124 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15385124 | pubmed:articleTitle | Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study. | lld:pubmed |
pubmed-article:15385124 | pubmed:affiliation | University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA. rlavey@chla.usc.edu | lld:pubmed |
pubmed-article:15385124 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15385124 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15385124 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:15385124 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:15385124 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:15385124 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15385124 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15385124 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15385124 | lld:pubmed |